Literature DB >> 21425256

Trends of stomach cancer mortality in Eastern Asia in 1950-2004: comparative study of Japan, Hong Kong and Singapore using age, period and cohort analysis.

Masahiro Tanaka1, Enbo Ma, Hideo Tanaka, Akiko Ioka, Toshitaka Nakahara, Hideto Takahashi.   

Abstract

To characterize the temporal trends of stomach cancer mortality in Eastern Asia and to better interpret the causes of the trends, we performed age, period and cohort analysis (APC analysis) on the mortality rates in Japan, Hong Kong and Singapore during 1950-2004, as well as the rates in the US as a control population. For the APC analysis, Holford's approach was used to avoid the identification problem. Age-standardized mortality rates (ASMR) decreased consistently in all four areas during the observation period in both males and females. Japan had the highest ASMR in both sexes, followed by Singapore, Hong Kong and the US, but the differences in ASMR among the four areas diminished with time. The results of APC analysis suggested that the decreasing mortality rates in Eastern Asia were caused by the combination of decreasing cohort effect since the end of the 1800s and decreasing period effect from the 1950s. The US showed similar results, but its decreases in the period and cohort effect preceded those of Eastern Asia. Possible causes for the decrease in the cohort effect include improvement in the socioeconomic conditions during childhood and a decrease in the prevalence of H. pylori infection, while possible causes for the decrease in the period effect include a decrease in dietary salt intake and improvements in cancer detection and treatment. These findings may help us to predict future changes in the mortality rates of stomach cancer.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21425256     DOI: 10.1002/ijc.26080

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

Review 1.  Clinical epidemiology of gastric cancer.

Authors:  Tiing Leong Ang; Kwong Ming Fock
Journal:  Singapore Med J       Date:  2014-12       Impact factor: 1.858

2.  Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients.

Authors:  Su Jin Lee; Jongtae Lee; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Kyoung-Mee Kim; In-Gu Do; Sin-Ho Jung; Dong-Seok Yim; Won Ki Kang
Journal:  Invest New Drugs       Date:  2013-09-07       Impact factor: 3.850

3.  Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).

Authors:  Seung Tae Kim; Soomin Ahn; Jeeyun Lee; Su Jin Lee; Se Hoon Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Kyoung-Mee Kim; Joon Oh Park
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-16       Impact factor: 4.553

4.  Cancer Incidence and Mortality in Asian Countries: A Trend Analysis.

Authors:  Junjie Huang; Chun Ho Ngai; Yunyang Deng; Man Sing Tin; Veeleah Lok; Lin Zhang; Jinqiu Yuan; Wanghong Xu; Zhi-Jie Zheng; Martin C S Wong
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

5.  Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.

Authors:  J H Yi; J Lee; J Lee; S H Park; J O Park; D-S Yim; Y S Park; H Y Lim; W K Kang
Journal:  Br J Cancer       Date:  2012-03-29       Impact factor: 7.640

6.  Health Disparities in Ischaemic Heart Disease Mortality in Hungary From 1970 to 2010: An Age-Period-Cohort Analysis.

Authors:  Krisztina Gero; Ehab S Eshak; Enbo Ma; Hideto Takahashi; Hiroyuki Noda; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2015-05-16       Impact factor: 3.211

7.  Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer.

Authors:  Jun Ho Yi; In-Gu Do; Jiryeon Jang; Seung Tae Kim; Kyoung-Mee Kim; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Jeeyun Lee
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

8.  Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population.

Authors:  Miki Watanabe; Hidemi Ito; Satoyo Hosono; Isao Oze; Chieko Ashida; Kazuo Tajima; Hisato Katoh; Keitaro Matsuo; Hideo Tanaka
Journal:  Cancer Sci       Date:  2015-10-30       Impact factor: 6.716

9.  Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer.

Authors:  Seung Tae Kim; Jeeyun Lee; Su Jin Lee; Se Hoon Park; Sin-Ho Jung; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Joon Oh Park
Journal:  Oncotarget       Date:  2016-04-26

10.  Incidence and mortality of stomach cancer in China, 2014.

Authors:  Lei Yang; Rongshou Zheng; Ning Wang; Yannan Yuan; Shuo Liu; Huichao Li; Siwei Zhang; Hongmei Zeng; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.